Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Intervention Research Grants To Promote the Health of People With Disabilities (Panel A), RFA-DD06-004, 27501 [E6-7212]

Download as PDF Federal Register / Vol. 71, No. 91 / Thursday, May 11, 2006 / Notices DC 20405; stanley.langfeld@gsa.gov, (202) 501–1737. Please cite FMR Bulletin 2005–03. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Dated: May 5, 2006. John G. Sindelar Acting Associate Administrator, Office of Governmentwide Policy. [FR Doc. E6–7221 Filed 5–10–06; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Intervention Research Grants To Promote the Health of People With Disabilities (Panel A), RFA–DD06–004 BILLING CODE 6820–RH–S In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Childhood Immunization, RFA–IP06–005, IP06– 007, and IP06–008 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: cchase on PROD1PC60 with NOTICES Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Childhood Immunization, RFA– IP06–005, IP06–007, and IP–06–008. Time and Date: 1 a.m.–4 p.m., June 16, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduct expert review of scientific merit of grant applications in response to Childhood Immunization, RFA–IP06–005, IP06–007, and IP06–008. For Further Information Contact: George Bockosh, B.S., M.S., Scientific Review Administrator, Pitt Building 20, Room 313, MS P05, Pittsburgh, PA 15236, Telephone 412–386–6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7208 Filed 5–10–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 16:29 May 10, 2006 Jkt 208001 Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Intervention Research Grants to Promote the Health of People with Disabilities (Panel A), RFA–DD06–004. Time and Date: 11:30 p.m.–5:30 p.m., June 12, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduce expert review of scientific merit of research applications in response to: Intervention Research Grants to Promote the Health of People with Disabilities, (Panel A), RFA– DD06–004. For Further Information Contact: Juliana Cyril, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333, Telephone 404–639– 0920. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7212 Filed 5–10–06; 8:45 am] 27501 Control and Prevention (CDC) announces the following meeting. Name: Healthcare Infection Control Practices Advisory Committee (HICPAC). Times and Dates: 8:30 a.m.–5 p.m., June 1, 2006; 8:30 a.m.–4 p.m., June 2, 2006. Place: CDC Roybal Campus, Bldg. 19, Auditorium B3, 1600 Clifton Road, Atlanta, GA 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Informatics and healthcare-associated infections; process for updating guidelines; updates on pandemic flu; updates on antimicrobial resistance and updates on CDC activities of interest to the committee. Agenda items are subject to change as priorities dictate. For Further Information Contact: Harriette Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, l600 Clifton Road, NE, M/S A–07, Atlanta, Georgia 30333, telephone 404–639–4035. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, M.S., Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7211 Filed 5–10–06; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC); Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Advisory Committee for Injury Prevention and Control, the Science and Program Review Subcommittee: Meeting In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) E:\FR\FM\11MYN1.SGM 11MYN1

Agencies

[Federal Register Volume 71, Number 91 (Thursday, May 11, 2006)]
[Notices]
[Page 27501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7212]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Intervention Research Grants To Promote the 
Health of People With Disabilities (Panel A), RFA-DD06-004

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Intervention Research Grants to 
Promote the Health of People with Disabilities (Panel A), RFA-DD06-
004.
    Time and Date: 11:30 p.m.-5:30 p.m., June 12, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: To conduce expert review of scientific 
merit of research applications in response to: Intervention Research 
Grants to Promote the Health of People with Disabilities, (Panel A), 
RFA-DD06-004.
    For Further Information Contact: Juliana Cyril, PhD, Scientific 
Review Administrator, CDC, 1600 Clifton Road NE., Mailstop D72, 
Atlanta, GA 30333, Telephone 404-639-0920.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 5, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-7212 Filed 5-10-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.